FDA issued a Warning Letter to BioReliance Corporation on 1/5/2009 for a later inspection.
483 BioReliance Oct 2005

483 BioReliance Oct 2005

Lynette Salisbury FDA$119.00 - Available Now

FDA investigators audited the BioReliance - Rockville, MD, United States facility and issued inspectional observations (via FDA 483) on 20 Oct 2005.

Product details

  • Category: Foods & Cosmetics / Medical Devices & Rad Health
  • Inspection end: 20 Oct 2005
  • Location: Rockville, United States
  • FEI: 1122041
Add To Cart